Tecvayli Injection
Product Images NDC 57894-449

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tecvayli (NDC 57894-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (30 mg/3 mL Vial Carton)

Packaging label for TECVAYLI (teclistamab-cqyv) injection, 30 mg/3 mL (10 mg/mL) strength. The label specifies it as a single-dose vial for subcutaneous injection, intended for use by healthcare providers only. It includes storage instructions to refrigerate at 2°C to 8°C and contains no preservatives. Manufactured by Janssen Biotech, Inc., with a warning not to combine vials of different concentrations to achieve a treatment dose.*

FDA Label Image

Principal Display Panel (153 mg/1.7 mL Vial Carton)

Label for TECVAYLI (teclistamab-cqyv) injection, 153 mg/1.7 mL (90 mg/mL) strength. The label indicates it is a single-dose vial for subcutaneous injection, for use by healthcare providers only. It includes storage instructions to refrigerate at 2°C to 8°C and contains no preservative. Manufactured by Janssen Biotech, Inc., Horsham, PA, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.